Reversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer.

scientific article published on July 1999

Reversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer. is ā€¦
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID10416587

P50authorShafaat RabbaniQ77959450
P2093author name stringGoltzman D
Rhim JS
Kremer R
Papavasiliou V
El Abdaimi K
P433issue14
P407language of work or nameEnglishQ1860
P921main subjectvitamin DQ175621
P304page(s)3325-3328
P577publication date1999-07-01
P1433published inCancer ResearchQ326097
P1476titleReversal of hypercalcemia with the vitamin D analogue EB1089 in a human model of squamous cancer
P478volume59

Reverse relations

cites work (P2860)
Q395266061,25-Dihydroxyvitamin D(3) regulates PTHrP expression via transcriptional, post-transcriptional and post-translational pathways
Q28359567Anti-oestrogen resistant human breast cancer cell lines are more sensitive towards treatment with the vitamin D analogue EB1089 than parent MCF-7 cells
Q39827903EB1089 inhibits the parathyroid hormone-related protein-enhanced bone metastasis and xenograft growth of human prostate cancer cells
Q37628495Effects of 1,25(OH)ā‚‚Dā‚ƒ on Cancer Cells and Potential Applications in Combination with Established and Putative Anti-Cancer Agents.

Search more.